col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


122 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Expert Review of Anti-infective Therapy
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―08 Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence Yang Yu, Guo-Fu Li, Jian Li, Lu-Yao Han, Zhi-Long Zhang, Tian-Shuo Liu, et al. (+6)
2 [GO] 2024―Jun―28 Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019-March 2023: a segmented interrupted time series analysis of over 53 million individuals Amanj Kurdi, Najla Al Mutairi, Kirmanj Bakir, Karwan Amen, Omeed Darweesh, Hardee Karwi, et al. (+3)
3 [GO] 2024―Jun―05 Impact of the COVID-19 pandemic on the utilization and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time series analysis Hayam Al Balushi, Amanj Kurdi, Najla Almutairi, Kirmanj Ismail Baker, Karwan Amen, Hardee Karwi, et al. (+2)
4 [GO] 2024―Jun―04 Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial
5 [GO] 2024―Jun―01 Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study Abiden Kapar, Songsong Xie, Zihao Guo, Yan Nan, Yaling Du, Xi Yin, et al. (+10)
6 [GO] 2024―May―04 Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and preexisting chronic obstructive pulmonary diseases Bo-Wen Shiau, Wan-Hsuan Hsu, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Po-Yu Huang, et al. (+3)
7 [GO] 2024―May―04 Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Wan-Hsuan Hsu, Min-Hsiang Chuang, Ya-Wen Tsai, et al. (+2)
8 [GO] 2024―May―02 Analysis of antimicrobial drug usage in psychiatric specialized hospitals during the pandemic in China Zhiqiang Du, Qin Zhou, Yuan Shen, Rongrong Lu, Ying Jiang, Haohao Zhu
9 [GO] 2024―Apr―03 The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants Chi-Kuei Hsu, Wan-Hsuan Hsu, Bo-Wen Shiau, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, et al. (+3)
10 [GO] 2024―Mar―25 Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease Chia-Chen Chen, Chi-Ya Huang, Jheng-Yan Wu, Mei-Yuan Liu, Min-Hsiang Chuang, Ting-Hui Liu, et al. (+9)
11 [GO] 2024―Mar―11 Long-term impact of COVID-19 pandemic on antibiotic use in primary care: lessons to optimize antimicrobial use Thais de Pando, Santiago Grau, Alexander Almendral, Daniel Echeverría-Esnal, Sergi Hernández, Enric Limon, Caridad Pontes
12 [GO] 2024―Mar―08 Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis Behnam Amani, Bahman Amani
13 [GO] 2024―Feb―01 Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China Pulin Li, Ling Huang, Rui Han, Min Tang, Guanghe Fei, Daxiong Zeng, Ran Wang
14 [GO] 2024―Jan―30 The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-19 Wen-Kuei Chang, Chieh-Jen Wang, Tung-Hu Tsai, Fang-Ju Sun, Chao-Hsien Chen, Kuan-Chih Kuo, et al. (+7)
15 [GO] 2024―Jan―29 Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases? Mohammed S. Razzaque
16 [GO] 2024―Jan―24 Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19 Muhammad Zeeshan Munir, Amer Hayat Khan, Tahir Mehmood Khan
17 [GO] 2024―Jan―08 Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India Lipin Lukose, Gursimran Kaur, Mohammed Asif M, Gail Ann Abraham, Kanav Khera, Subeesh K Viswam, et al. (+5)
18 [GO] 2024―Jan―05 The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19 Jheng-Yan Wu, Mei-Yuan Liu, Mei-Chuan Lee, Kuo-Chuan Hung, Wan-Hsuan Hsu, Ya-Wen Tsai, et al. (+6)
19 [GO] 2023―Dec―26 Bacterial Co-infections, secondary Infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications Zia Ul Mustafa, Arfa Batool, Hadia Ibrar, Muhammad Salman, Yusra Habib Khan, Tauqeer Hussain Malhi, et al. (+3)
20 [GO] 2023―Dec―15 Immunocompromised patients and COVID-19: how do we protect those most at risk? Jochen Schneider, Johanna Erber, Lutz Renders, Christoph D. Spinner
21 [GO] 2023―Nov―15 Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Wan-Hsuan Hsu, Min-Hsiang Chuang, Ya-Wen Tsai, et al. (+2)
22 [GO] 2023―Oct―05 Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis Wan-Hsuan Hsu, Bo-Wen Shiau, Ting-Hui Liu, Jheng-Yan Wu, Ya-Wen Tsai, Po-Yu Huang, et al. (+3)
23 [GO] 2023―Sep―05 Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis Bincai Wei, Ruhao Zhang, Huatang Zeng, Liqun Wu, Rongxin He, Junyao Zheng, et al. (+4)
24 [GO] 2023―Aug―01 Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19 Gangireddy Navitha Reddy, Akanksha Jogvanshi, Sana Naikwadi, Rajesh Sonti
25 [GO] 2023―Jul―23 Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study Xiaodan Guo, Yihua Lin, Fengming He, Ying Jin, Simian Chen, Ting Li, et al. (+3)
26 [GO] 2023―Jul―20 The Impact of COVID-19 on the HIV Continuum of Care: Challenges, Innovations and Opportunities Jenny Yeon Hee Kim, Shannon K. Barth, Anne K. Monroe, Sarah Ahsan, Janja Kovacic, Siena Senn, Amanda D. Castel
27 [GO] 2023―Jun―16 Tocilizumab for the treatment of COVID-19 Robert Flisiak, Marta Flisiak-Jackiewicz, Piotr Rzymski, Dorota Zarębska-Michaluk
28 [GO] 2023―Mar―29 Letter in response to ‘The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis’ by Tsai et al Endry H.T. Lim, Alexander P.J. Vlaar, Sanne de Bruin, Matthijs C. Brouwer, Diederik van de Beek
29 [GO] 2023―Mar―07 Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials Jheng-Yan Wu, Po-Yu Huang, Ting-Hui Liu, Chia-Yin Kuo, Ya-Wen Tsai, Hung-Jen Tang, Chih-Cheng Lai
30 [GO] 2023―Feb―24 The contributions of multidrug resistant clones to the success of pandemic Extra-intestinal Pathogenic Escherichia coli Johann DD Pitout, Gisele Peirano, Rebekah DeVinney
31 [GO] 2023―Feb―20 Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis Amanj Kurdi, Niketa Platt, Aidan Morrison, Euan Proud, Karen Gronkowski, Tanja Mueller, et al. (+3)
32 [GO] 2023―Feb―09 Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach Ashfaq Ahmad, Zhandaulet Makhmutova, Wenwen Cao, Sidra Majaz, Amr Amin, Yingqiu Xie
33 [GO] 2022―Nov―29 What is the impact of SARS-CoV-2 infection during pregnancy on child immunity? Liliana Gabrielli, Giulia Piccirilli, Evangelia Petrisli, Simona Venturoli, Eva Caterina Borgatti, Alice Balboni, et al. (+2)
34 [GO] 2022―Nov―28 Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19 induced lung injury Seyed MohammadReza Hashemian, Tayebeh Farhadi, Mohammad Varahram, Ali Akbar Velayati
35 [GO] 2022―Nov―22 Infliximab as a potential treatment for COVID-19 Matthew P. Velez, Matthew W. McCarthy
36 [GO] 2022―Nov―18 The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis Chi-Lun Tsai, Chih-Cheng Lai, Ching-Yi Chen, Ho-Sheng Lee
37 [GO] 2022―Nov―01 Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Tzu-Chieh Weng, Teng-Song Weng, Chih-Cheng Lai, Chien-Ming Chao, Jui-Hsiang Wang
38 [GO] 2022―Oct―13 Monoclonal antibodies for the treatment of COVID-19 infection in children Kelly M Ling, Michael Dougan
39 [GO] 2022―Oct―11 Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review Andrew Ustianowski
40 [GO] 2022―Sep―15 Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial Nazanin Majidi, Effat Bahadori, Soheila Shekari, Maryam Gholamalizadeh, Shirin Tajaddod, Marjan Ajami, et al. (+10)
41 [GO] 2022―Jul―15 The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose David Luque Paz, Pierre Sesques, Florent Wallet, Emmanuel Bachy, Florence Ader
42 [GO] 2022―Jul―05 Ivermectin Role in COVID-19 Treatment (IRICT): single center, adaptive, randomized, double-blind, placebo controlled, clinical trial Ahmed Hanei Elshafie, Hozaifa Khalil Elsawah, Mohamed Hammad, Eman Mohamed Sweed, Ahmed Salah Seif, Muhammad Mostafa Abdel Ghaffar, et al. (+3)
43 [GO] 2022―Jul―04 The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Chih-Cheng Lai, Wang-Chun Chen, Ching-Yi Chen, Yu-Feng Wei
44 [GO] 2022―May―26 Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava, Abdelwahab Omri
45 [GO] 2022―May―16 How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review Qian Wang, Xing Wu, Qunying Mao, Fan Gao, Mingchen Liu, Ziyang Song, et al. (+2)
46 [GO] 2022―May―13 Outpatient treatment options to address the SARS-CoV-2 variant Omicron Matthew W. McCarthy
47 [GO] 2022―Apr―22 False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews Yu-Pei Yang, Li-Li Huang, Shuang-jun Pan, Dan Xu, Zhu Liduzi Jiesisibieke, Tao-Hsin Tung
48 [GO] 2022―Apr―12 Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2? Jairo Azócar-Gallardo, Alex Ojeda-Aravena, Jorge Carrizo Largo, Claudio Hernández-Mosqueira
49 [GO] 2022―Feb―25 Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): amulticenter real-world evidence Yahya A. Mohzari, Ahmad Alamer, Majda Alattas, Ahmed A. Alrashed, Nura A. Alshehab, Turkiah K. Alkhaldi, et al. (+23)
50 [GO] 2022―Jan―29 Containment strategies for COVID-19 in India: lessons from the second wave Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal
51 [GO] 2022―Jan―28 COVID-19 and Vitamin D (Co-VIVID Study): a systematic review and meta-analysis of randomized controlled trials Seshadri Reddy Varikasuvu, Balachandar Thangappazham, Alekya Vykunta, Pragathi Duggina, Munikumar Manne, Hemanth Raj, Sowjanya Aloori
52 [GO] 2021―Dec―20 Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis Hideyuki Negoro, Christos Chatziantonio, Mohammed S. Razzaque
53 [GO] 2021―Dec―13 Antimicrobial consumption in patients with COVID-19: A systematic review and meta-analysis Sidra Khan, Syed Shahzad Hasan, Stuart E. Bond, Barbara R Conway, Mamoon A. Aldayeb
54 [GO] 2021―Dec―13 Ivermectin: a pathway out of the pandemic or another dead end? Daniel Echeverría-Esnal, Santiago Grau
55 [GO] 2021―Dec―04 Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 infection among healthcare workers: a prospective cohort study Akshay Rao, Sundar Kumar Veluswamy, Banashankari Gunjiganur Shankarappa, Rithika Manjunatha Reddy, Nethravathi Umesh, Lissy John, et al. (+2)
56 [GO] 2021―Dec―02 Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review Paraskevas Filippidis, Julien Vionnet, Oriol Manuel, Matteo Mombelli
57 [GO] 2021―Nov―30 Evaluation of favipiravir in the treatment of COVID-19 based on the real-world Weishang Deng, Changyuan Yang, Sensen Yang, Haitao Chen, Zhikun Qiu, Jisheng Chen
58 [GO] 2021―Nov―19 Ethical challenges of prospective clinical trials during the COVID-19 pandemic Madison S. McCarthy, Matthew W. McCarthy
59 [GO] 2021―Nov―10 Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study Mehdi Azizmohammad Looha, Mostafa Rezaei-Tavirani, Mohammad Rostami-Nejad, Shahriar Janbazi, Elaheh Zarean, Payam Amini, et al. (+8)
60 [GO] 2021―Nov―06 Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials Shao-Huan Lan, Chiung-Kai Wang, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin
61 [GO] 2021―Nov―06 Clinical efficacy and safety of interferon-β-containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Wang-Chun Chen, Chi-Kuei Hsu, Ching-Yi Chen, Chih-Cheng Lai, Shun-Hsing Hung, Wei-Ting Lin
62 [GO] 2021―Oct―30 Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials Chia Siang Kow, Amaan Javed, Dinesh Ramachandram, Syed Shahzad Hasan
63 [GO] 2021―Oct―30 Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics? Anatoly Mayburd
64 [GO] 2021―Oct―25 Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Abolfazl Akbari, Mahya Razmi, Alireza Sedaghat, Seyyed Mohammad Matin Alavi Dana, Mahdi Amiri, Ali Mohammad Halvani, et al. (+2)
65 [GO] 2021―Oct―13 Indomethacin: An exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19 Nishant Shekhar, Harpinder Kaur, Phulen Sarma, Ajay Prakash, Bikash Medhi
66 [GO] 2021―Oct―07 Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box Stefan Biendl, Cécile Häberli, Jennifer Keiser
67 [GO] 2021―Sep―20 Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis Ronal Yosua Limen, Rudyanto Sedono, Adhrie Sugiarto, Timotius Ivan Hariyanto
68 [GO] 2021―Sep―03 Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition Nihad Adnan, Shahad Saif Khandker, Ahsanul Haq, Mousumi Akter Chaity, Abdul Khalek, Anawarul Quader Nazim, et al. (+9)
69 [GO] 2021―Aug―06 The effects of the pandemic in cases of heart failure Gustavo Teixeira Bristot, Nikolas de Vargas Raupp, Eliane Mazzuco dos Santos, Elonir Gomes
70 [GO] 2021―Aug―04 Anti-inflammatory Effects of GLP-1 in Patients with COVID-19 Saharnaz Sazgarnejad, Niloufar Yazdanpanah, Nima Rezaei
71 [GO] 2021―Aug―03 Cardiovascular complications of COVID-19: towards better understanding, diagnosis, monitoring and management Marco Vicenzi, Massimiliano Ruscica, Tannaz Jamialahmadi, Amirhossein Sahebkar
72 [GO] 2021―Jul―29 Antiviral drugs for coronavirus disease 2019 (COVID-19): A systematic review with network meta-analysis George Okoli, Rasheda Rabbani, Amenah Al-Juboori, Leslie Copstein, Nicole Askin, Ahmed M. Abou-Setta
73 [GO] 2021―Jul―26 The rise of Mucormycosis in Covid-19 patients in India Migresh Bhatia
74 [GO] 2021―Jul―06 Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study Mahmoud El-Bendary, Sherief abd-elsalam, Tamer Elbaz, Wafaa El-Akel, Ahmed Cordie, Tamer Elhadidy, et al. (+11)
75 [GO] 2021―Jul―06 Molecular Detections of Coronavirus: Current and Emerging Methodologies Mingkun Diao, Lang Lang, Juan Feng, Rongsong Li
76 [GO] 2021―Jun―30 The use of remdesivir for the management of patients with moderate-to-severe COVID-19: A systematic review Kaeshaelya Thiruchelvam, Chia Siang Kow, Muhammad Hadi, Syed Shahzad Hasan
77 [GO] 2021―Jun―19 Diagnosis, prevention, and treatment of coronavirus disease: a review Manoj Kumar Sarangi, Sasmita Padhi, Shrivardhan Dheeman, Santosh Kumar Karn, L. D. Patel, Dong Kee Yi, Sitansu Sekhar Nanda
78 [GO] 2021―Jun―11 Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy Sadaf Jamal Gilani, May Bin-Jumah, Muhammad Shahid Nadeem, Imran Kazmi
79 [GO] 2021―Jun―05 NSAIDs/Nitazoxanide/Azithromycin Repurposed for COVID-19: Potential Mitigation of the Cytokine Storm Interleukin-6 Amplifier via Immunomodulatory Effects Mina T. Kelleni
80 [GO] 2021―May―21 Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice Radu Crisan Dabija, Ileana Antohe, Antigona Trofor, Sabina A Antoniu
81 [GO] 2021―Apr―16 Lifestle and rehabilitation during the COVID-19 pandemic: guidance for health professionals and support for exercise and rehabilitation programs Cássia da Luz Goulart, Rebeca Nunes Silva, Murilo Rezende Oliveira, Solange Guizilini, Isadora Salvador Rocco, Vanessa Marques Ferreira Mendez, et al. (+4)
82 [GO] 2021―Apr―12 Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2 Masoumeh Sadat Mousavi Maleki, Mosayeb Restamian, Hamid Madanchi
83 [GO] 2021―Apr―09 Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management Shreya R. Savla, Kedar S. Prabhavalkar, Lokesh K. Bhatt
84 [GO] 2021―Mar―30 System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: Preliminary experience of a tertiary care institute in India Praveen Kumar-M, Ritin Mohindra, Ashish Balla, Nusrat Shafiq, Vikas Suri, Deepa Kumari, et al. (+6)
85 [GO] 2021―Mar―24 Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: An observational prospective open label user survey Klang Shmuel, Megiddo Dalia, Lapidot Tair, Naparstek Yaakov
86 [GO] 2021―Mar―19 Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits Anindita Banerjee, Upasana Ganguly, Sarama Saha, Suddhachitta Chakrabarti, Reena V Saini, Ravindra K Rawal, et al. (+2)
87 [GO] 2021―Mar―15 Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials Nida Bokharee, Yusra Habib Khan, Aisha Khokhar, Tauqeer Hussain Mallhi, Nasser Hadal Alotaibi, Maria Rasheed
88 [GO] 2021―Mar―08 The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives Massimo Andreoni, Matteo Bassetti, Salvatore Corrao, Francesco Giuseppe De Rosa, Vincenzo Esposito, Marco Falcone, et al. (+6)
89 [GO] 2021―Feb―23 COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention Ashif Iqubal, Mohammad Kashif Iqubal, Farazul Hoda, Abul Kalam Najmi, Syed Ehtaishamul Haque
90 [GO] 2021―Jan―15 Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children Mohammad Zarei, Deepanwita Bose, Soheila Ali Akbari Ghavimi, Masoud Nouri-Vaskeh, Mehdi Mohammadi, Amirhossein Sahebkar
91 [GO] 2020―Dec―29 A review on favipiravir: the properties, function, and usefulness to treat COVID-19 Seyed MohammadReza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati
92 [GO] 2020―Dec―23 Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress Md. Jamal Hossain, S. M. Abdur Rahman
93 [GO] 2020―Dec―16 Exacerbation of antimicrobial resistance: another casualty of the covid-19 pandemic? Mohammed S. Razzaque
94 [GO] 2020―Dec―16 Potential Effectiveness and Adverse Implications of Repurposing Doxycycline in COVID-19 Treatment Lekshmi Narendrakumar, Iype Joseph, Sabu Thomas
95 [GO] 2020―Dec―14 The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies Zahra Payandeh, Niloufar Mohammad Khani, Mohsen Nabbi, Saeed Khalili, Masoumeh Rajabibazl, Zahra Houjaghani, Masoomeh Dadkhah
96 [GO] 2020―Dec―12 An Update on COVID-19 Pandemic: The Epidemiology, Pathogenesis, Prevention and Treatment Strategies Hin Fung Tsang, Lawrence Wing Chi Chan, William Chi Shing Cho, Allen Chi Shing Yu, Aldrin Kay Yuen Yim, Amanda Kit Ching Chan, et al. (+5)
97 [GO] 2020―Dec―03 Recent progress in the repurposing of drugs/molecules for the management of COVID-19 Divakar Sharma, Adinarayana Kunamneni
98 [GO] 2020―Nov―17 COVID-19 and inhibitors of the renin-angiotensin-aldosterone system Musaddique Hussain, Qaiser Jabeen, Fiaz-ud-Din Ahmad, Mobeen Fatima, Saira Shaukat, Abdul Majeed, et al. (+2)
99 [GO] 2020―Nov―14 Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review Betsy Ann Joseph, Mahmoud Dibas, Kirk W. Evanson, Geeta Paranjape, Charan Thej Reddy Vegivinti, Pragadeesh Thamarai Selvan, et al. (+15)
100 [GO] 2020―Nov―13 Drug repurposing: new strategies for addressing COVID-19 outbreak Pravin Shende, Bhakti Khanolkar, R.S. Gaud
101 [GO] 2020―Nov―08 Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints Mahendra Rai, Shital Bonde, Alka Yadav, Yulia Plekhanova, Anatoly Reshetilov, Indarchand Gupta, et al. (+3)
102 [GO] 2020―Oct―13 Could bacteriophages be the answer to the COVID-19 crisis? Antal Martinecz, Marcin W. Wojewodzic
103 [GO] 2020―Oct―12 Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease Stuti Bhagat, Nisha Yadav, Juhi Shah, Harsh Dave, Shachee Swaraj, Shashank Tripathi, Sanjay Singh
104 [GO] 2020―Sep―14 COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment and follow up Amir Tajbakhsh, Seyed Mohammad Gheibi hayat, Hajar Taghizadeh, Ali Akbari, Masoumeh Einabadi, Amir Savardashtaki, et al. (+2)
105 [GO] 2020―Sep―12 The effect of antivirals on COVID-19: a systematic review Nafisa Hussain, Anusha Yoganathan, Savini Hewage, Samiha Alom, Amer Harky
106 [GO] 2020―Aug―27 Azithromycin in the treatment of COVID-19: a review Daniel Echeverría-Esnal, Clara Martin-Ontiyuelo, María Eugenia Navarrete-Rouco, Marta De-Antonio Cuscó, Olivia Ferrández, Juan Pablo Horcajada, Santiago Grau
107 [GO] 2020―Aug―20 COVID-19: fighting the invisible enemy with microRNA Neeraj Chauhan, Meena Jaggi, Subhash C. Chauhan, Murali M. Yallapu
108 [GO] 2020―Aug―19 MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale Paul E. Marik, Pierre Kory, Joseph Varon, Jose Iglesias, G Umberto Meduri
109 [GO] 2020―Aug―04 Resolution of coronavirus disease 2019 (COVID-19) Khaled Habas, Chioma Nganwuchu, Fanila Shahzad, Rajendran Gopalan, Mainul Haque, Sayeeda Rahman, et al. (+2)
110 [GO] 2020―Jul―30 Call for proper documentation of COVID-19 deaths in poor resource setting: a necessity for management of future occurrences Ahoma V Mbanuzuru, Chukwuemeka C Okoro, Chinyere M Mbanuzuru, Christian C Ibeh
111 [GO] 2020―Jul―24 Integrative role of traditional and modern technologies to combat COVID-19 Mohammad Heiat, Mohammad-Reza Hashemi-Aghdam, Fatemeh Heiat, Mona Rastegar Shariat Panahi, Hossein Aghamollei, Mehrdad Moosazadeh Moghaddam, et al. (+3)
112 [GO] 2020―Jul―22 Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection Marco Infante, Camillo Ricordi, Rodolfo Alejandro, Massimiliano Caprio, Andrea Fabbri
113 [GO] 2020―Jul―22 Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study Krzysztof Tomasiewicz, Anna Piekarska, Justyna Stempkowska-Rejek, Sylwia Serafińska, Aleksandra Gawkowska, Miłosz Parczewski, et al. (+6)
114 [GO] 2020―Jul―16 Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends George Cherry, John Rocke, Michael Chu, Jacklyn Liu, Matt Lechner, Valerie J. Lund, B. Nirmal Kumar
115 [GO] 2020―Jul―14 The Use of IV vitamin C for patients with COVID-19: a single center observational study Raul Hiedra, Kevin Bryan Lo, Mohammad Elbashabsheh, Fahad Gul, Robert Matthew Wright, Jeri Albano, et al. (+2)
116 [GO] 2020―Jul―07 Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine; from HIV-1 infection to COVID-19 Sara Naghipour, Mahsa Ghodousi, Sara Rahsepar, Sepideh Elyasi
117 [GO] 2020―Jun―23 Can nanotechnology help in the fight against COVID-19? Gabriela Palestino, Ileana García-Silva, Omar González-Ortega, Sergio Rosales-Mendoza
118 [GO] 2020―Jun―17 Repurposing minocycline for COVID-19 management: mechanisms, opportunities and challenges Harmanjit Singh, Ashish Kumar Kakkar, Prerna Chauhan
119 [GO] 2020―Jun―14 Possible therapeutic agents for COVID-19: a comprehensive review Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay, Mohamed Gomaa Kamel
120 [GO] 2020―May―18 Old and re-purposed drugs for the treatment of COVID-19 Shio-Shin Jean, Po-Ren Hsueh
121 [GO] 2020―May―04 Quadruple therapy for asymptomatic COVID-19 infection patients Ling Wang, Xiaopeng Xu, Junshan Ruan, Saijin Lin, Jinhua Jiang, Hong Ye
122 [GO] 2020―Mar―29 How could artificial intelligence aid in the fight against coronavirus? Hadi M Yassine, Zubair Shah
 [1] 

122 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec